drug protocol number

A3405 V01

drug sponsor

Novartis

drug study

Ultibro breezhaler

drug trial site

King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah)

drug status

Ongoing

drug phase